532041 — Hindustan Bio Sciences Income Statement
0.000.00%
Last trade - 00:00- IN₹70.73m
- IN₹92.92m
- IN₹7.04m
Annual income statement for Hindustan Bio Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 9.22 | 10.5 | 8.13 | 7.04 |
| Cost of Revenue | ||||
| Gross Profit | 3.52 | 4.1 | 3.19 | 2.55 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 9.56 | 9.96 | 7.14 | 8.15 |
| Operating Profit | -0.339 | 0.57 | 0.996 | -1.11 |
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.379 | 0.533 | 0.982 | -0.793 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.405 | 0.576 | 1.01 | -0.79 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.405 | 0.576 | 1.01 | -0.79 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.405 | 0.576 | 1.01 | -0.789 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.039 | 0.056 | 0.1 | -0.08 |
| Dividends per Share |